Drug-Target Information
Drug Name Target Name Drug Type Target Type Source Drug MeSHID Interaction Score Drug Status Target Action
tandutinib receptor-type tyrosine-protein kinase flt3 small molecule NA drugbank , DGIDB leukemia[MeSHID:D007938]
Anaplasia[MeSHID:D000708]
Mixed Oligodendroglioma-Astrocytoma[MeSHID:D009837]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Mixed oligoastrocytoma[MeSHID:D001254]		 0.73 investigational inhibitor
tandutinib receptor-type tyrosine-protein kinase flt3 small molecule NA drugbank , DGIDB leukemia[MeSHID:D007938]
Anaplasia[MeSHID:D000708]
Mixed Oligodendroglioma-Astrocytoma[MeSHID:D009837]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Mixed oligoastrocytoma[MeSHID:D001254]		 0.73 investigational unknown
tandutinib fms-like tyrosine kinase 3 NA Successful target TTD , DGIDB leukemia[MeSHID:D007938]
Anaplasia[MeSHID:D000708]
Mixed Oligodendroglioma-Astrocytoma[MeSHID:D009837]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Mixed oligoastrocytoma[MeSHID:D001254]		 0.73 discontinued in phase 2 inhibitor
tandutinib fms-like tyrosine kinase 3 NA Successful target TTD , DGIDB leukemia[MeSHID:D007938]
Anaplasia[MeSHID:D000708]
Mixed Oligodendroglioma-Astrocytoma[MeSHID:D009837]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Mixed oligoastrocytoma[MeSHID:D001254]		 0.73 discontinued in phase 2 unknown
tandutinib platelet-derived growth factor d small molecule NA drugbank leukemia[MeSHID:D007938]
Anaplasia[MeSHID:D000708]
Mixed Oligodendroglioma-Astrocytoma[MeSHID:D009837]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Mixed oligoastrocytoma[MeSHID:D001254]		 NA investigational unknown
click here to return to the previous page